Cargando…

Health problems of adolescent and adult patients with 21-hydroxylase deficiency

Twenty-one-hydroxylase deficiency (21-OHD) is one of the most common forms of congenital adrenal hyperplasias. Since the disease requires life-long steroid hormone replacement, transition from pediatric clinical care to adolescent and adult care is necessary. Recently, several studies have shown tha...

Descripción completa

Detalles Bibliográficos
Autor principal: Tajima, Toshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207803/
https://www.ncbi.nlm.nih.gov/pubmed/30393437
http://dx.doi.org/10.1297/cpe.27.203
_version_ 1783366588477472768
author Tajima, Toshihiro
author_facet Tajima, Toshihiro
author_sort Tajima, Toshihiro
collection PubMed
description Twenty-one-hydroxylase deficiency (21-OHD) is one of the most common forms of congenital adrenal hyperplasias. Since the disease requires life-long steroid hormone replacement, transition from pediatric clinical care to adolescent and adult care is necessary. Recently, several studies have shown that morbidity and quality of life in adolescent and adult patients with 21-OHD are impaired by obesity, hypertension, diabetes mellitus, impaired glucose tolerance, dyslipidemia, and osteoporosis. In addition, excess adrenal androgen impairs fertility in both females and males. This mini review discusses the current health problems in adolescent and adult patients with 21-OHD and ways to prevent them.
format Online
Article
Text
id pubmed-6207803
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-62078032018-11-02 Health problems of adolescent and adult patients with 21-hydroxylase deficiency Tajima, Toshihiro Clin Pediatr Endocrinol Review Twenty-one-hydroxylase deficiency (21-OHD) is one of the most common forms of congenital adrenal hyperplasias. Since the disease requires life-long steroid hormone replacement, transition from pediatric clinical care to adolescent and adult care is necessary. Recently, several studies have shown that morbidity and quality of life in adolescent and adult patients with 21-OHD are impaired by obesity, hypertension, diabetes mellitus, impaired glucose tolerance, dyslipidemia, and osteoporosis. In addition, excess adrenal androgen impairs fertility in both females and males. This mini review discusses the current health problems in adolescent and adult patients with 21-OHD and ways to prevent them. The Japanese Society for Pediatric Endocrinology 2018-10-30 2018 /pmc/articles/PMC6207803/ /pubmed/30393437 http://dx.doi.org/10.1297/cpe.27.203 Text en 2018©The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Tajima, Toshihiro
Health problems of adolescent and adult patients with 21-hydroxylase deficiency
title Health problems of adolescent and adult patients with 21-hydroxylase deficiency
title_full Health problems of adolescent and adult patients with 21-hydroxylase deficiency
title_fullStr Health problems of adolescent and adult patients with 21-hydroxylase deficiency
title_full_unstemmed Health problems of adolescent and adult patients with 21-hydroxylase deficiency
title_short Health problems of adolescent and adult patients with 21-hydroxylase deficiency
title_sort health problems of adolescent and adult patients with 21-hydroxylase deficiency
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207803/
https://www.ncbi.nlm.nih.gov/pubmed/30393437
http://dx.doi.org/10.1297/cpe.27.203
work_keys_str_mv AT tajimatoshihiro healthproblemsofadolescentandadultpatientswith21hydroxylasedeficiency